降钙素原检测在重症肺感染诊断治疗的意义被引量：4

下载PDF

导出

摘要目的探讨降钙素原(PCT)在肺感染患者的诊断价值和疗效监测。方法选择338例肺感染或合并肺感染的患者,所有患者检测血常规、PCT、痰细菌培养、鲎试验和胸部CR或CT。结果细菌感染组患者PCT水平明显高于真菌感染组和痰培养阴性组(P<0.05),革兰阴性菌感染患者PCT水平明显高于革兰阳性菌感染患者(P<0.05),细菌感染组在治疗5d后PCT下降明显(P<0.05),真菌感染组PCT治疗前后变化不明显(P>0.05)。结论 PCT可作为细菌感染的血清标志物和抗菌药物疗效的有效监测指标。

作者王晓东王然李凤焕陈兆喆

机构地区中国人民解放军第二五四医院检验科

出处《国际检验医学杂志》 CAS 2016年第18期2621-2623,共3页 International Journal of Laboratory Medicine

关键词降钙素原感染细菌鲎试验 G试验

分类号 R563.1 [医药卫生—呼吸系统] R446.1 [医药卫生—诊断学]

引文网络
相关文献

参考文献12

1宋鉴清,周雯雯,满东亮,杨志东,丁奇.降钙素原在新生儿感染性疾病中的临床价值[J].检验医学与临床,2014,11(8):1013-1015. 被引量：9
2汪丽儿,杜菁,汪彤.重症监护室患者血清降钙素原与CRP相关指标测定的临床意义[J].国际检验医学杂志,2014,35(14):1848-1850. 被引量：8
3Marc E,M6nager C, Moulin F, et al. Procalcitonin and vi- ral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak[J]. Arch Pediatr, 2002, 9(4) ..358-364.
4Soler N, Esperatti M, Ewig S, et al. Sputum purulence- guided antibiotic use in hospitalised patients with exacer bations of COPD[J]. Eur Respir J, 2012,40 (6) : 1344- 1353.
5Wenzel RP, Fowler AA. Acute bronchitis[J]. N Engl J Med, 2006,355 (20) .. 2125-2130.
6Karlsson S, Heikkinen M,Pettill V, et al. Predictive value of procalcitonin decrease in patients with severe sepsis:a prospective observational study[J]. Crit Care, 2010, 14 (6) .. R205.
7Martini A, Gottin L, Menestrina N, et al. Procalcitonin levels in surgical patients at risk of candidemia[J]. J In- fect, 2010,60(6) = 425-430.
8Dou YH,Du JK, Liu HL, et al. The role of proealcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis[J]. Diagn Microbiol Infect Dis, 2013,76(4) .. 464-469.
9卢先雷,罗宇鹏,曹志跃,杨进,朱文磊,王平,刘波,朱勇,孙长贵.降钙素原与(1,3)-β-D葡聚糖对肺部感染诊断的临床效能[J].国际检验医学杂志,2015,36(9):1200-1202. 被引量：9
10Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis[J]. Diagn Microbiol Infect Dis, 2012,73 (3) : 221-227.

二级参考文献34

1宋秀琴,时兢,俞亚芬,穆会君.动态检测血清降钙素原水平对多发伤患者伤情判断的临床意义[J].中国急救医学,2004,24(7):488-489. 被引量：8
2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量：3052
3Mathew B,Roy D D,Kumar TV. The use of proealcitonin as a marker of sepsis in children[J]. J Clin Diagn Res, 2013,7(2) :305-307.
4Assicot M,Gendrel D, Carsin H,et al. High serum procal- citonin concentrations in patients with sepsis and infection [J]. Lancet, 1993,341(8844) : 515-518.
5Tulek B,Koylu H, Kanat F, et al. Serum C-reactive pro- tein and procalcitonin levels in non-small cell lung Cancer patients[J]. Contemp Oncol, 2013,17(1) : 68-72.
6Freyne B, Divilley R, Kissoon-Harrison G, et al. Field tes- ting the utility of procalcitonin and the acute infantile ob- servation score in febrile infants 6 to 36 months old pres- enting to the pediatric emergency department with no ob- vious focus of infection[J]. Clin Pediatr(Phila), 2013,52 (6) :503-506.
7Hoeboer SH,Groeneveld AB. Changes in circulating pro- calcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients[J]. PLoS One,2013,8(6) :e65564.
8Lee H. Procalcitonin as a biomarker of infectious diseases [J]. Korean J Intern Meal,g013,28(3) :285-291.
9Stolz D,Christ- Crain M, P, ingisser R,et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy[J]. Chest, 2007,131 (1) :9-19.
10Stocker M, Fontana M, Helou S, et al. Use of procalcition in guided decision making to shorten antibiotic therapy in suspected neonatal early onset sepsis: prospect ive randomized intervention trial[J]. Neonatology,2009,97(2) :165-174.